:?

Zivojin Jevtic1, Melanie Allram2, Florian Grebien2,3

  • 1Department of Biomedicine (DBM), University Children's Hospital Basel, University of Basel, Switzerland.

HemaSphere
|June 30, 2023
PubMed
概括

核生物分子凝聚物或子凝聚物是急性髓性白血病 (AML) 发展的关键. 本综述探讨了它们在AML中的作用和潜在的治疗向.